S&P 500   4,662.85 (+0.08%)
DOW   35,911.81 (-0.56%)
S&P 500   4,662.85 (+0.08%)
DOW   35,911.81 (-0.56%)
S&P 500   4,662.85 (+0.08%)
DOW   35,911.81 (-0.56%)
S&P 500   4,662.85 (+0.08%)
DOW   35,911.81 (-0.56%)
NASDAQ:KRYS

Krystal Biotech News Headlines

$62.28
+1.91 (+3.16%)
(As of 01/14/2022 12:00 AM ET)
Add
Compare
Today's Range
$59.03
$62.41
50-Day Range
$39.81
$88.24
52-Week Range
$38.86
$102.99
Volume
139,102 shs
Average Volume
186,270 shs
Market Capitalization
$1.39 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.91
Get Krystal Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for KRYS and its competitors with MarketBeat's FREE daily newsletter.

Media Mentions By Week

Krystal Biotech Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

KRYS
News Sentiment

0.40

0.32

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

KRYS Articles
This Week

4

1

KRYS Articles
Average Week



Krystal Biotech (NASDAQ:KRYS) News Headlines Today

SourceHeadline
marketbeat.com logoKrystal Biotech (NASDAQ:KRYS) Lifted to "Buy" at Zacks Investment Research
marketbeat.com - January 11 at 4:19 AM
MarketBeat logoaTyr Pharma (NASDAQ:LIFE) vs. Krystal Biotech (NASDAQ:KRYS) Financial Contrast
americanbankingnews.com - January 16 at 8:20 AM
finance.yahoo.com logoJeune Aesthetics Leadership to Present at Octane’s 3rd Annual Aesthetics Tech Summit
finance.yahoo.com - January 13 at 4:50 PM
finance.yahoo.com logoDo Insiders Own Lots Of Shares In Krystal Biotech, Inc. (NASDAQ:KRYS)?
finance.yahoo.com - January 7 at 9:19 AM
finance.yahoo.com logoCould This Soaring Biotech Stock Make You Rich?
finance.yahoo.com - December 15 at 9:21 AM
finance.yahoo.com logoKrystal: Impressive DEB Clincal Trial Results Merit a New Price Target
finance.yahoo.com - December 3 at 7:58 AM
finance.yahoo.com logoWhy Krystal Biotech's Shares Rose More Than 77% This Week
finance.yahoo.com - December 2 at 8:29 PM
finance.yahoo.com logoWhy Krystal Biotech Stock Is Retreating Today
finance.yahoo.com - December 1 at 2:27 PM
finance.yahoo.com logoKrystal Biotech Announces Pricing of $200 Million Public Offering of Common Stock
finance.yahoo.com - December 1 at 12:09 AM
finance.yahoo.com logoKrystal Biotech Shares More Than Double After Positive VYJUVEK Trial Results
finance.yahoo.com - November 29 at 7:14 PM
msn.com logoKrystal Biotech Shares More Than Double During Premarket Monday: What Investors Need To Know
msn.com - November 29 at 1:58 PM
finance.yahoo.com logo5 Top Stock Gainers for Monday: Zscaler, Krystal Biotech, Adagio
finance.yahoo.com - November 29 at 1:58 PM
finance.yahoo.com logoFirst Gene Therapy for Skin, From Krystal, Heals Wounded Kids
finance.yahoo.com - November 29 at 1:58 PM
investorplace.com logoKRYS Stock Alert: The Study Results That Have Krystal Biotech Rocketing 118% Today
investorplace.com - November 29 at 12:01 PM
marketwatch.com logoKrystal Biotech Shares More Than Double After Dystrophic EB Trial Meets Objectives
marketwatch.com - November 29 at 8:43 AM
finance.yahoo.com logoKrystal Biotech Announces Positive Topline Results from GEM-3 Pivotal Trial of VYJUVEK™ in Patients with Dystrophic Epidermolysis Bullosa
finance.yahoo.com - November 29 at 8:43 AM
finance.yahoo.com logoKrystal Biotech Announces Positive Topline Results from GEM-3 Pivotal Trial of VYJUVEK™ in Patients with Dystrophic Epidermolysis Bullosa
finance.yahoo.com - November 29 at 8:43 AM
finance.yahoo.com logoJeune Aesthetics to Present Pre-clinical Data Highlighting the Potential of KB303 in Elastin Production at the ASDS 2021 Virtual Meeting
finance.yahoo.com - November 19 at 8:14 AM
finance.yahoo.com logoKrystal's new Pittsburgh gene therapy center to be operational in 2022
finance.yahoo.com - November 8 at 4:15 PM
finance.yahoo.com logoKrystal Biotech Reports Third Quarter 2021 Financial Results and Provides Update on Operational Progress
finance.yahoo.com - November 8 at 9:53 AM
nasdaq.com logoUnusual Options Activity in American International Group (AIG), Laboratory Corporation of America (LH), and Krystal Biotech (KRYS)
nasdaq.com - October 28 at 12:29 PM
finance.yahoo.com logoKrystal Biotech Announces Completion of the GEM-3 Pivotal Phase 3 Study Evaluating B-VEC for the Treatment of Dystrophic Epidermolysis Bullosa
finance.yahoo.com - October 26 at 9:09 AM
finance.yahoo.com logoKrystal Biotech Announces Virtual Presentation of Pre-clinical Data on KB407 for the Treatment of Cystic Fibrosis
finance.yahoo.com - October 19 at 6:50 PM
finance.yahoo.com logoKrystal Biotech Announces Virtual Presentation of Pre-clinical Data on KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency at ESGCT
finance.yahoo.com - October 14 at 10:04 AM
benzinga.com logoKrystal Biotech and GeneDx Announce Collaboration To Provide No-Charge Genetic Testing For Patients With Suspected Dystrophic Epidermolysis Bullosa
benzinga.com - October 12 at 10:37 AM
finance.yahoo.com logoKrystal Biotech to Present at the Chardan 5th Annual Genetic Medicines Conference
finance.yahoo.com - October 1 at 4:10 PM
finance.yahoo.com logoKrystal Biotech Receives Approval from the Human Research Ethics Committee in Australia for Phase 1 Trial of KB407 for Cystic Fibrosis
finance.yahoo.com - September 29 at 5:59 PM
bizjournals.com logoPittsburgh-based biotech firm names European leader
bizjournals.com - September 17 at 8:04 PM
nasdaq.com logoHow The Pieces Add Up: LABU Targets $101
nasdaq.com - September 16 at 2:17 PM
finance.yahoo.com logoKrystal Biotech Appoints Laurent Goux as General Manager of Europe
finance.yahoo.com - September 15 at 8:39 AM
finance.yahoo.com logoKrystal Biotech to Present Data on DEB and B-VEC at the DEBRA International Conference 2021
finance.yahoo.com - September 9 at 8:39 AM
finance.yahoo.com logoKrystal Biotech to Participate in H.C. Wainwright 23rd Annual Global Investment Conference
finance.yahoo.com - September 7 at 5:03 PM
nasdaq.com logoCommit To Purchase Krystal Biotech At $45, Earn 71% Annualized Using Options
nasdaq.com - August 19 at 5:49 PM
msn.com logoBRIEF-Krystal Biotech Reports Q2 Results
msn.com - August 10 at 5:49 PM
finance.yahoo.com logoKrystal Biotech Reports Second Quarter 2021 Financial Results and Provides Update on Operational Progress
finance.yahoo.com - August 9 at 9:58 AM
ca.finance.yahoo.com logoJeune Aesthetics Announces Initiation of Dosing in Efficacy Cohort of KB301 Phase 1 trial to Assess Improvement in Skin Quality
ca.finance.yahoo.com - August 2 at 6:27 PM
nasdaq.com logoKrystal Biotech, Inc. Common Stock (KRYS)
nasdaq.com - August 1 at 5:42 PM
nasdaq.com logoKrystal Biotech Breaks Below 200-Day Moving Average - Notable for KRYS
nasdaq.com - July 14 at 4:34 PM
bizjournals.com logoKrystal Biotech picks Whiting-Turner for gene therapy center construction
bizjournals.com - July 7 at 6:04 PM
finance.yahoo.com logoKrystal Biotech's KB105 Shows Detectable, Functionally Active TGM-1 Enzyme In Genetic Skin Condition
finance.yahoo.com - July 2 at 2:31 PM
finance.yahoo.com logoKrystal Biotech Provides Update on the Clinical Trial Evaluating Topical KB105 for the Treatment of TGM-1 Associated Ichthyosis
finance.yahoo.com - July 1 at 5:06 PM
nasdaq.com logoKrystal Biotech is Now Oversold (KRYS)
nasdaq.com - May 13 at 12:31 PM
seekingalpha.com logoKrystal Biotech EPS misses by $0.16
seekingalpha.com - May 12 at 11:04 AM
bizjournals.com logoPittsburgh biotech names Alnylam exec as new chief commercial officer
bizjournals.com - May 4 at 5:53 PM
bizjournals.com logoKrystal Biotech names new chief commercial officer
bizjournals.com - May 3 at 3:19 PM
finance.yahoo.com logoKrystal Biotech Appoints Andy Orth as Chief Commercial Officer
finance.yahoo.com - May 3 at 9:44 AM
finance.yahoo.com logoKrystal Biotech Stock Sees Relative Strength Rating Jump To Noteworthy Territory
finance.yahoo.com - April 29 at 6:46 PM
finance.yahoo.com logoKrystal Biotech Announces Virtual Presentation of Data from its Vector-Encoded-Antibody Platform at ASGCT
finance.yahoo.com - April 27 at 7:03 PM
finance.yahoo.com logoKrystal Biotech Provides Update on Pivotal GEM-3 Study of B-VEC for DEB
finance.yahoo.com - April 26 at 7:05 PM
nasdaq.com logoKrystal Biotech (NASDAQ:KRYS) Is In A Good Position To Deliver On Growth Plans
nasdaq.com - April 23 at 9:11 PM
msn.com logoBRIEF-Krystal Biotech Provides Updates from its Rare Genetic Lung Disease Pipeline
msn.com - April 20 at 12:53 AM
Get Krystal Biotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for KRYS and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 1/17/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.